Serial endocrine follow‐up is planned to monitor for the potential emergence of additional pituitary hormone deficiencies, as GLI2‐related hypopituitarism may evolve over time (Franca et al. 2010; Roessler et al. 2003). This evidence concerns the gene GLI2 and hypopituitarism.